When she was just 23, Sarah Power sat with her mum in a hospital room, waiting to hear whether she had tested positive for a disease that would drastically cut her life expectancy. ‘It was a really harrowing moment,’ Sarah, now 41, recalls. ‘Nothing could prepare me for the news I was about to receive.’
That day she was told she carried the gene mutation for Huntington’s Disease, a fatal neurodegenerative disease which presents as a triad of progressive psychiatric, cognitive, and motor symptoms, and would develop it at some point in her lifetime. ‘I fell to pieces. But it wasn’t just the pain I was feeling that hurt, it was knowing how my mum felt – grieving to see how much my diagnosis affected her,’ Sarah tells Metro.
The diagnosis hadn’t come as a huge surprise because both her dad and his mum, Sarah’s grandmother, also had Huntington’s. ‘I vividly remember sitting in our living room when I was five, being told by someone from the Huntington’s Disease Association that my grandma had this disease,’ she tells Metro. ‘They were explaining it was hereditary, which didn’t mean a huge amount to me at the time, but I did feel this darkness in the room.’
Eight years later, Sarah’s grandmother passed away, the cause of death listed as Huntington’s. Sarah’s dad insisted he’d had genetic testing and didn’t carry the gene mutation, and would constantly deny he was at risk. ‘He stuck with that story until the day he died,’ Sarah remembers. ‘He just wouldn’t travel there as a proud man.’
Sarah was desperate to acquire tested herself as a teenager, but knew it wouldn’t be possible until adulthood. Soon after her 18th birthday, she received a letter inviting her to a genetic counselling appointment. Two years later, blood tests confirmed she would at some point develop Huntington’s Disease.
‘I cried more than I thought possible,’ she says. ‘The world was still turning, but it was as though it was stood still for a although.’ After losing two babies through IVF screening, Sarah was able to carry her first daughter full-term. She later unexpectedly became pregnant with a second daughter, choosing not to test for the gene mutation.
Now a stay-at-home mum, Sarah has no regrets – but she has spent years suppressing fears for herself, and for her second daughter. ‘Normally, onset is between 30 and 50,’ she says. ‘I am pre-symptomatic, but it feels like I’m a ticking time bomb.’
Recently, Sarah received a glimmer of hope with news of a potential new treatment for Huntington’s Disease. ‘I had to read the email several times – I couldn’t sleep that night,’ she says. ‘It’s the breakthrough we’ve all been hoping and praying for.’
The Promise of New Treatments and a Shift in Huntington’s Disease Management
For decades, Huntington’s Disease has been a devastating diagnosis with limited options. However, the recent announcement of a potential new treatment, as highlighted by Sarah’s story, signals a turning point. The Huntington’s Disease Association reports that around 8,000 people in the UK live with the condition, with another 32,000 at risk. This new treatment, which could slow the disease’s progression by up to 75%, offers a beacon of hope for those affected.
The treatment currently requires a major operation lasting over 12 hours, and regulatory approval is still pending in Europe and the UK after initial progress in the US. However, the development represents a significant leap forward in tackling this complex neurodegenerative disease.
Gene Therapy and the Future of Neurological Disease Treatment
The potential treatment for Huntington’s Disease utilizes gene therapy, a rapidly evolving field with implications far beyond this single condition. Gene therapy aims to address the root cause of genetic diseases by modifying or replacing faulty genes. This approach is being explored for a range of neurological disorders, including Parkinson’s Disease and Alzheimer’s Disease.
The success of gene therapy in Huntington’s Disease could pave the way for similar treatments for other inherited neurological conditions, offering the possibility of slowing or even halting disease progression. This shift represents a move away from managing symptoms towards addressing the underlying genetic causes.
Community Advocacy and Accelerated Research
The advancement of this treatment wasn’t solely a scientific achievement. As reported by HDBuzz, the Huntington’s Disease community played a crucial role in securing a meeting with the FDA to discuss the regulatory pathway for the treatment. Over 48,000 signatures were gathered on petitions, and community members engaged with lawmakers to highlight the urgent necessitate for new therapies.
This demonstrates the power of patient advocacy in accelerating research and bringing innovative treatments to market. The Huntington’s Disease Foundation was among the organizations involved in this advocacy effort.
Psychological Support and Living with Uncertainty
While medical advancements offer hope, the psychological impact of Huntington’s Disease remains significant. Dr. Sarah Gunn, a Clinical Psychologist working with Huntington’s patients, emphasizes the importance of mental health support. Resources from the Huntington’s Disease Association, including guided relaxation scripts and webinars, can help individuals cope with the emotional challenges of the disease.
Sarah Power’s story highlights the emotional toll of knowing one’s genetic predisposition to a fatal illness. The uncertainty surrounding the onset of symptoms and the impact on family members can be profoundly distressing. Access to psychological interventions and support groups is crucial for individuals and families navigating this complex journey.
Frequently Asked Questions
- What is Huntington’s Disease? A fatal neurodegenerative disease causing progressive psychiatric, cognitive, and motor symptoms.
- Is Huntington’s Disease hereditary? Yes, it is caused by a genetic mutation and is passed down through families.
- What are the early signs of Huntington’s Disease? Changes in personality, clumsiness, loss of balance, and difficulty learning new things.
- Is there a cure for Huntington’s Disease? Currently, there is no cure, but new treatments like gene therapy offer hope for slowing disease progression.
The new treatment for Huntington’s Disease
Cath Stanley BEM, Chief Executive Huntington’s Disease Association tells Metro:
‘Around 8,000 people in the UK are living with Huntington’s disease, an inherited condition that slowly takes away control over movement, thinking and behaviour.
Another 32,000 are at risk, unsure whether they’ll one day face the same future. Huntington’s affects the brain’s nervous system due to a faulty gene.
For many, symptoms initiate in their 30s or 40s just as careers, families, and futures are taking shape. As the disease progresses, people often lose their independence and need round-the-clock care.
We are thrilled by the early results of this new Huntington’s disease treatment, which suggest it could slow the condition’s progression by up to 75%.
The full trial results haven’t been published yet, and the company is seeking approval in the US before applying to European and UK regulators, which could take several years. It also appears it may only work for people at certain stages of the disease.
While the procedure is currently a major operation, lasting more than 12 hours, this is a huge step forward.’
MORE: I had no idea my itchy skin meant I had a deadly disease
MORE: I discovered the murky world of ‘minor attracted people’ – it’s even more disturbing than you think
MORE: ‘I organise luxury holidays for the world’s richest travellers – nothing shocks me any more’
